alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-D-GalNAc

Term ID

CHEBI:61578

Synonyms

(Gal)1 (GalNAc)1 (GlcNAc)1 (Neu5Ac)1
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->6)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-galactopyranose
2-acetamido-2-deoxy-beta-D-glucosyl-(1->6)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulonosyl-(2->3)-beta-D-galactosyl-(1->3)]-2-acetamido-2-deoxy-D-galactose
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-[beta-D-GlcpNAc-(1->6)]-D-GalpNAc
beta-D-GlcNAc-(1->6)-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)]-D-GlcNAc
NeuAc(alpha2-3)Gal(beta1-3)[GlcNAc(beta1-6)]GalNAc

Definition

A amino tetrasaccharide comprising D-GalNAc having a β-D-GlcNAc residue at the 6-position and a α-Neu5Ac-(2→3)-β-D-Gal residue at the 3-position.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-D-GalNAc

Phenotype where environments contain alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-D-GalNAc

Phenotype modified by environments containing alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-D-GalNAc

Phenotype affecting alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-[beta-D-GlcNAc-(1->6)]-D-GalNAc

Human Disease Model